Ascent Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $709K | Buy |
2,747
+14
| +0.5% | +$3.61K | 0.03% | 400 |
|
|
2025
Q1 | $612K | Buy |
2,733
+33
| +1% | +$7.39K | 0.03% | 409 |
|
|
2024
Q4 | $617K | Sell |
2,700
-224
| -8% | -$51.2K | 0.05% | 343 |
|
|
2024
Q3 | $714K | Buy |
2,924
+48
| +2% | +$11.7K | 0.05% | 328 |
|
|
2024
Q2 | $551K | Buy |
2,876
+207
| +8% | +$39.6K | 0.04% | 347 |
|
|
2024
Q1 | $529K | Sell |
2,669
-760
| -22% | -$151K | 0.05% | 342 |
|
|
2023
Q4 | $626K | Buy |
3,429
+339
| +11% | +$61.9K | 0.06% | 311 |
|
|
2023
Q3 | $443K | Sell |
3,090
-886
| -22% | -$127K | 0.05% | 331 |
|
|
2023
Q2 | $713K | Buy |
3,976
+549
| +16% | +$98.4K | 0.08% | 272 |
|
|
2023
Q1 | $750K | Buy |
3,427
+1,465
| +75% | +$321K | 0.08% | 264 |
|
|
2022
Q4 | $408K | Sell |
1,962
-33
| -2% | -$6.87K | 0.05% | 330 |
|
|
2022
Q3 | $446K | Buy |
1,995
+45
| +2% | +$10.1K | 0.05% | 309 |
|
|
2022
Q2 | $469K | Sell |
1,950
-286
| -13% | -$68.8K | 0.06% | 305 |
|
|
2022
Q1 | $542K | Buy |
2,236
+368
| +20% | +$89.2K | 0.06% | 287 |
|
|
2021
Q4 | $439K | Buy |
+1,868
| New | +$439K | 0.06% | 315 |
|